Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Andresen, , Helene,
DOB: 17-OCT-1939 (Age: 86)
Gender: female
Address:
Kristiansenberget 2
0172 Sørensen (Norway)
ID: 3450-170343-2 (ECI)
Report
Date: 23-NOV-2024
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Oslo universitetssykehus (Ullevål)
0155 Oslo (Norway)
Specimen
Collected: 23-NOV-2024

Chemistry

Test 23-NOV-2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.9 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 73.1 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 9.7 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.6 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.3 8.6 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 141.1 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.8 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 107.0 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 23.3 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 155.3 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 143.6 10 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 76.2 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 50.5 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All measured parameters are within normal limits for this 85-year-old female patient. Glycemic control, renal function, electrolytes, and lipid profile are unremarkable. No laboratory evidence of acute or chronic metabolic, renal, or lipid abnormalities at this time. Continued routine monitoring is recommended.